InsiderTrades.com logo
War on Elon Escalates…
From Porter & Company   |   Ad
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Click here to learn how you can benefit from its widespread distribution.

EYPT Insider Trading

Insider Ownership Percentage: 4.74%
Insider Buying (Last 12 Months): $89,515,138.62
Insider Selling (Last 12 Months): $45,265,564.57

EyePoint Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at EyePoint Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

EyePoint Pharmaceuticals Share Price & Price History

Current Price: $9.10
Price Change: ▲ Price Increase of +0.22 (2.48%)
As of 09/13/2024 01:00 AM ET

This chart shows the closing price history over time for EYPT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
War on Elon Escalates…
From Porter & Company   |   Ad
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Click here to learn how you can benefit from its widespread distribution.

EyePoint Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2024Wendy F DiciccoDirectorBuy2,567$7.79$19,996.939,967View SEC Filing Icon  
7/12/2024David R GuyerDirectorSell11,625$10.06$116,947.501,850View SEC Filing Icon  
5/14/2024David R GuyerDirectorSell11,625$12.65$147,056.255,550View SEC Filing Icon  
5/6/2024Cormorant Asset Management, LpMajor ShareholderBuy850,000$11.86$10,081,000.008,325,000View SEC Filing Icon  
4/18/2024Cormorant Asset Management, LpMajor ShareholderBuy581,765$18.03$10,489,222.957,475,000View SEC Filing Icon  
2/2/2024David Scott JonesSVPSell209$28.49$5,954.4137,962View SEC Filing Icon  
1/26/2024Dario A PaggiarinoInsiderSell49,325$25.66$1,265,679.5036,505View SEC Filing Icon  
1/25/2024David Scott JonesSVPSell600$25.00$15,000.0037,962View SEC Filing Icon  
1/23/2024Dario A PaggiarinoInsiderSell5,135$25.00$128,375.0036,505View SEC Filing Icon  
1/23/2024David Scott JonesSVPSell900$25.00$22,500.0037,962View SEC Filing Icon  
1/11/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.75$14,812,500.006,893,235View SEC Filing Icon  
1/11/2024Ye LiuDirectorSell1,910,500$19.45$37,159,225.00100,221View SEC Filing Icon  
1/9/2024Cormorant Asset Management, LpMajor ShareholderBuy105,000$21.32$2,238,600.006,143,235View SEC Filing Icon  
1/8/2024Dario A PaggiarinoInsiderSell22,913$21.13$484,151.6936,505View SEC Filing Icon  
12/13/2023Dario A PaggiarinoInsiderSell1,458$20.00$29,160.0025,707View SEC Filing Icon  
12/8/2023Cormorant Asset Management, LpMajor ShareholderBuy588,235$17.00$9,999,995.006,038,235View SEC Filing Icon  
12/6/2023Ye LiuDirectorSell266,242$18.41$4,901,515.222,010,721View SEC Filing Icon  
12/4/2023Cormorant Asset Management, LpMajor ShareholderBuy1,919,057$21.82$41,873,823.745,450,000View SEC Filing Icon  
12/4/2023Michael Craig PineInsiderSell45,000$22.00$990,000.005,343View SEC Filing Icon  
9/1/2023Ew Healthcare Partners, L.P.Major ShareholderSell20,000$9.90$198,000.003,490,921View SEC Filing Icon  
8/30/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,976$10.92$665,857.923,589,416View SEC Filing Icon  
8/28/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,858$11.71$712,647.183,738,246View SEC Filing Icon  
8/24/2023Ew Healthcare Partners, L.P.Major ShareholderSell139,280$14.62$2,036,273.603,883,760View SEC Filing Icon  
8/22/2023Ew Healthcare Partners, L.P.Major ShareholderSell46,778$14.62$683,894.364,144,143View SEC Filing Icon  
5/30/2023Ye LiuDirectorSell1$6.00$6.003,010,721View SEC Filing Icon  
See Full Table
My grim warning about AI stocks
From Porter & Company   |   Ad
Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.
So go here now to read my new report The Big AI Die-Up… while you still can.

SEC Filings (Institutional Ownership Changes) for EyePoint Pharmaceuticals (NASDAQ:EYPT)

99.41% of EyePoint Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EYPT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

EyePoint Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2024Fiera Capital Corp677,038$5.89M0.0%+0.9%1.300%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.630,769$5.49M0.0%N/A1.211%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC640,274$5.57M0.1%+8.6%1.229%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company 68,043$0.59M0.0%-11.1%0.131%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC580,716$5.05M0.0%-71.6%1.115%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C877,790$7.64M0.1%+51.4%1.685%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC28,723$0.25M0.0%-51.4%0.054%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC46,456$0.40M0.0%-66.5%0.087%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC476,250$4.14M0.0%+842.5%0.890%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC12,793$0.11M0.0%-16.6%0.025%Search for SEC Filing on Google Icon
8/13/2024Canada Pension Plan Investment Board15,600$0.14M0.0%-88.0%0.030%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC152,800$1.33M0.0%+112.5%0.293%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP28,447$0.25M0.0%-3.9%0.055%Search for SEC Filing on Google Icon
8/9/2024Greenwich Wealth Management LLC10,800$94K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.290,212$2.53M0.0%-54.9%0.557%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC8,905$77K0.0%-66.9%0.017%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System13,251$0.12M0.0%+9.7%0.025%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc127,694$1.11M0.0%-10.6%0.245%Search for SEC Filing on Google Icon
8/1/2024Fiera Capital Corp677,038$5.89M0.0%+0.9%1.300%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers76,833$0.67M0.0%+32.6%0.148%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.120,721$1.05M0.0%+205.5%0.232%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank10,888$95K0.0%+271.0%0.021%Search for SEC Filing on Google Icon
7/26/2024Legato Capital Management LLC19,437$0.17M0.0%-72.9%0.037%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp204,892$1.78M0.0%+32.6%0.393%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC76,288$0.66M0.0%N/A0.146%Search for SEC Filing on Google Icon
7/8/2024Woodstock Corp55,387$0.48M0.0%+80.0%0.106%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC11,639$0.24M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.938,591$19.40M0.2%N/A1.802%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System43,275$0.89M0.0%+884.2%0.083%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC26,856$0.56M0.0%N/A0.052%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD2,465,815$50.97M0.0%-2.3%4.735%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.18,378$0.38M0.0%+38.4%0.035%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.3,719$77K0.0%+44.0%0.007%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,396,228$49.53M0.0%+17.8%4.601%Search for SEC Filing on Google Icon
5/9/2024Lord Abbett & CO. LLC242,580$5.02M0.0%-34.6%0.466%Search for SEC Filing on Google Icon
5/8/2024Entropy Technologies LP13,512$0.28M0.0%N/A0.026%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC10,121$0.21M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/8/2024Legacy Capital Group California Inc.33,832$0.70M0.3%N/A0.065%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank86,700$1.79M0.0%N/A0.166%Search for SEC Filing on Google Icon
5/3/2024Essex Investment Management Co. LLC149,819$3.10M0.6%+1.5%0.288%Search for SEC Filing on Google Icon
5/1/2024Capstone Investment Advisors LLC11,130$0.23M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC18,040$0.37M0.0%+26.5%0.035%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.9,393$0.19M0.0%+129.9%0.018%Search for SEC Filing on Google Icon
4/9/2024Woodstock Corp30,778$0.64M0.1%+38.3%0.062%Search for SEC Filing on Google Icon
3/21/2024Healthcare of Ontario Pension Plan Trust Fund137,000$3.17M0.0%N/A0.275%Search for SEC Filing on Google Icon
2/22/2024Sierra Summit Advisors LLC22,613$0.52M0.2%N/A0.048%Search for SEC Filing on Google Icon
2/20/2024Quarry LP3,000$69K0.0%-75.0%0.006%Search for SEC Filing on Google Icon
2/15/2024PFM Health Sciences LP170,871$3.95M0.2%N/A0.363%Search for SEC Filing on Google Icon
2/14/2024Artia Global Partners LP50,000$1.16M0.3%N/A0.106%Search for SEC Filing on Google Icon
2/14/2024Ghisallo Capital Management LLC108,634$2.51M0.3%N/A0.231%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.81,160$1.88M0.8%-53.9%0.172%Search for SEC Filing on Google Icon
2/14/2024Ratan Capital Management LP45,000$1.04M0.7%N/A0.096%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC4,724$0.11M0.0%+36.0%0.010%Search for SEC Filing on Google Icon
2/13/2024Bard Associates Inc.14,600$0.34M0.1%-23.6%0.031%Search for SEC Filing on Google Icon
2/12/2024Scotia Capital Inc.8,963$0.21M0.0%-90.1%0.019%Search for SEC Filing on Google Icon
2/12/2024Monashee Investment Management LLC175,000$4.04M0.7%N/A0.372%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc142,894$3.30M0.0%+99.0%0.304%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.4,640,651$107.25M0.1%+11.8%9.859%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP48,760$1.13M0.0%-53.4%0.104%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG574,169$13.27M0.0%+9.0%1.220%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.80,780$1.87M0.0%+7.4%0.172%Search for SEC Filing on Google Icon
2/8/2024Nicholas Investment Partners LP53,236$1.23M0.1%N/A0.113%Search for SEC Filing on Google Icon
2/8/2024First Turn Management LLC317,010$7.33M1.1%N/A0.673%Search for SEC Filing on Google Icon
2/8/2024Essex Investment Management Co. LLC147,541$3.41M0.7%-28.8%0.313%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC23,794$0.55M0.0%-51.4%0.051%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.28,530$0.66M0.0%N/A0.061%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund21,511$0.50M0.0%+176.6%0.046%Search for SEC Filing on Google Icon
2/1/2024Jennison Associates LLC1,066,240$24.64M0.0%N/A2.265%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.674,824$15.60M0.0%+194.0%1.434%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio23,300$0.54M0.0%-5.3%0.050%Search for SEC Filing on Google Icon
1/26/2024Toth Financial Advisory Corp5,000$0.12M0.0%+42.9%0.011%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.15,584$0.36M0.0%+6.0%0.033%Search for SEC Filing on Google Icon
1/24/2024DekaBank Deutsche Girozentrale35,000$0.82M0.0%N/A0.074%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.4,085$94K0.0%N/A0.009%Search for SEC Filing on Google Icon
1/16/2024Legato Capital Management LLC59,347$1.37M0.2%-23.3%0.126%Search for SEC Filing on Google Icon
1/12/2024FNY Investment Advisers LLC1,210$27K0.0%N/A0.003%Search for SEC Filing on Google Icon
1/8/2024Woodstock Corp22,253$0.51M0.1%N/A0.047%Search for SEC Filing on Google Icon
1/1/2024Deutsche Bank AG21,764$0.17M0.0%+4.0%0.046%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.30,042$0.24M0.0%N/A0.085%Search for SEC Filing on Google Icon
11/15/2023Scotia Capital Inc.90,963$0.73M0.0%+144.9%0.258%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.176,080$1.41M0.3%-43.4%0.499%Search for SEC Filing on Google Icon
11/15/2023Acuta Capital Partners LLC300,128$2.40M1.6%-21.4%0.850%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.1,736,503$13.88M0.0%-2.6%4.918%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.22,682$0.18M0.1%N/A0.064%Search for SEC Filing on Google Icon
11/14/2023Sherbrooke Park Advisers LLC12,620$0.10M0.0%N/A0.036%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP104,618$0.84M0.0%N/A0.296%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.229,535$1.83M0.0%+456.3%0.650%Search for SEC Filing on Google Icon
11/9/2023Essex Investment Management Co. LLC207,160$1.66M0.3%-1.3%0.587%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG526,848$4.21M0.0%+487.6%1.492%Search for SEC Filing on Google Icon
11/8/2023HighTower Advisors LLC252,972$2.02M0.0%-15.3%0.716%Search for SEC Filing on Google Icon
11/8/2023Janney Montgomery Scott LLC17,500$0.14M0.0%N/A0.050%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund7,776$62K0.0%-50.4%0.022%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC45,659$0.37M0.0%+103.4%0.129%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC48,968$0.39M0.0%+318.5%0.139%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc71,800$0.57M0.0%N/A0.203%Search for SEC Filing on Google Icon
10/26/2023Mirae Asset Global Investments Co. Ltd.14,702$0.12M0.0%N/A0.042%Search for SEC Filing on Google Icon
10/26/2023Strs Ohio24,600$0.20M0.0%N/A0.070%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp115,690$0.92M0.0%+11.9%0.331%Search for SEC Filing on Google Icon
10/12/2023Toth Financial Advisory Corp3,500$28K0.0%+250.0%0.010%Search for SEC Filing on Google Icon
10/12/2023Legato Capital Management LLC77,401$0.62M0.1%-4.5%0.221%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
EyePoint Pharmaceuticals logo
EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.
Read More on EyePoint Pharmaceuticals

Today's Range

Now: $9.10
Low: $8.99
High: $9.72

50 Day Range

MA: $8.87
Low: $7.58
High: $10.54

52 Week Range

Now: $9.10
Low: $5.67
High: $30.99

Volume

696,489 shs

Average Volume

965,690 shs

Market Capitalization

$487.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Who are the company insiders with the largest holdings of EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals' top insider investors include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Ew Healthcare Partners, LP (Major Shareholder)
  3. Ye Liu (Director)
  4. David Scott Jones (SVP)
  5. Dario A Paggiarino (Insider)
  6. Wendy F Dicicco (Director)
  7. David R Guyer (Director)
  8. Michael Craig Pine (Insider)
Learn More about top insider investors at EyePoint Pharmaceuticals.

Who are the major institutional investors of EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals' top institutional shareholders include:
  1. Deerfield Management Company L.P. Series C — 1.69%
  2. Fiera Capital Corp — 1.30%
  3. Fiera Capital Corp — 1.30%
  4. Perceptive Advisors LLC — 1.23%
  5. Point72 Asset Management L.P. — 1.21%
  6. Millennium Management LLC — 1.11%
Learn More about top institutional investors of EyePoint Pharmaceuticals stock.

Which major investors are selling EyePoint Pharmaceuticals stock?

Within the last quarter, EYPT stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Federated Hermes Inc.
  3. Canada Pension Plan Investment Board
  4. Squarepoint Ops LLC
  5. Legato Capital Management LLC
  6. AQR Capital Management LLC
  7. Quest Partners LLC
  8. TD Asset Management Inc
During the previous year, company insiders that have sold EyePoint Pharmaceuticals company stock include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Ew Healthcare Partners, LP (Major Shareholder)
  3. Ye Liu (Director)
  4. David Scott Jones (SVP)
  5. Dario A Paggiarino (Insider)
Learn More investors selling EyePoint Pharmaceuticals stock.

Which major investors are buying EyePoint Pharmaceuticals stock?

Within the last quarter, EYPT stock was purchased by institutional investors including:
  1. Point72 Asset Management L.P.
  2. Cubist Systematic Strategies LLC
  3. Deerfield Management Company L.P. Series C
  4. Panagora Asset Management Inc.
  5. Renaissance Technologies LLC
  6. SG Americas Securities LLC
  7. Perceptive Advisors LLC
  8. Bank of New York Mellon Corp
During the previous year, these company insiders have bought EyePoint Pharmaceuticals stock:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Ew Healthcare Partners, LP (Major Shareholder)
Learn More investors buying EyePoint Pharmaceuticals stock.
War on Elon Escalates…
From Porter & Company   |   Ad
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Click here to learn how you can benefit from its widespread distribution.